Your browser doesn't support javascript.
loading
Systemic therapy for pre-treated malignant mesothelioma: A systematic review, meta-analysis and network meta-analysis of randomised controlled trials.
Banna, Giuseppe Luigi; Signori, Alessio; Curioni-Fontecedro, Alessandra; Cortellini, Alessio; Ponzano, Marta; Giunta, Emilio Francesco; Rebuzzi, Sara Elena; Chan, Samuel; Gebbia, Vittorio; van Eeden, Ronwyn; Addeo, Alfredo; Ottensmeier, Christian.
Afiliación
  • Banna GL; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy. Electronic address: giuseppe.banna@ircc.it.
  • Signori A; Department of Health Sciences Section of Biostatistics, University of Genova, Genoa, Italy.
  • Curioni-Fontecedro A; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.
  • Cortellini A; Department of Surgery and Cancer, Imperial College London, Faculty of Medicine, Hammersmith Hospital, London, United Kingdom.
  • Ponzano M; Department of Health Sciences Section of Biostatistics, University of Genova, Genoa, Italy.
  • Giunta EF; Department of Experimental Medicine, Università Degli Studi Della Campania Luigi Vanvitelli, Naples, Italy.
  • Rebuzzi SE; Medical Oncology, Ospedale San Paolo, Savona, Italy.
  • Chan S; Oncology Department, Portsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom.
  • Gebbia V; La Maddalena Cancer Center, Palermo, Italy.
  • van Eeden R; The Medical Oncology Centre of Rosebank, University of the Witwatersrand, Johannesburg, South Africa.
  • Addeo A; Department of Oncology, Geneva University Hospital, Geneve, Switzerland.
  • Ottensmeier C; Department of Molecular & Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.
Eur J Cancer ; 166: 287-299, 2022 05.
Article en En | MEDLINE | ID: mdl-35358809

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mesotelioma Maligno / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mesotelioma Maligno / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido